¼¼°èÀÇ ½ÅÀå ±â´É °Ë»ç ½ÃÀå
Kidney Function Tests
»óǰÄÚµå : 1545549
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 179 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,163,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,489,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ½ÅÀå ±â´É °Ë»ç ½ÃÀåÀº 2030³â±îÁö 16¾ï ´Þ·¯¿¡ µµ´Þ

2023³â¿¡ 11¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ½ÅÀå ±â´É °Ë»ç ½ÃÀåÀº 2030³â¿¡´Â 16¾ï ´Þ·¯¿¡ ´ÞÇϸç, ºÐ¼® ±â°£ÀÎ 2023-2030³âÀÇ CAGRÀº 4.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ µö½ºÆ½Àº CAGR 5.4%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 7¾ï 6,500¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÏȸ¿ë ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 4.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 330¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ½ÅÀå ±â´É °Ë»ç ½ÃÀåÀº 2023³â¿¡ 3¾ï 330¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023-2030³â¿¡ CAGR 4.5%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â 2¾ï 4,440¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.8%¿Í 3.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ½ÅÀå ±â´É °Ë»ç ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÀÇ·á ºÐ¾ß ÀλçÀÌÆ®

½ÅÀå ±â´É °Ë»ç°¡ ½ÅÀå ÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇÏ´Â µ¥ ÇʼöÀûÀÎ ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

½ÅÀå ±â´É °Ë»ç´Â ½ÅÀå ±â´ÉÀ» Æò°¡ÇÏ°í ½ÅÀå Áúȯ ¹× ±â´É Àå¾ÖÀÇ Â¡Èĸ¦ Á¶±â¿¡ ¹ß°ßÇÏ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ Áø´Ü ÅøÀÔ´Ï´Ù. ÀϹÝÀûÀ¸·Î Ç÷û Å©·¹¾ÆÆ¼´Ñ, Ç÷Áß ¿ä¼ÒÁú¼Ò(BUN), »ç±¸Ã¼¿©°úÀ²(GFR), ¼Òº¯ ¾ËºÎ¹Î°ú °°Àº ÆÄ¶ó¹ÌÅ͸¦ ÃøÁ¤ÇÏ¿© ½ÅÀå °Ç°­ »óÅ¿¡ ´ëÇÑ Áß¿äÇÑ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ¸¸¼ºÄáÆÏº´(CKD)Àº Á¶¿ëÈ÷ ÁøÇàµÇ´Â °æ¿ì°¡ ¸¹À¸¸ç, Áõ»óÀÌ ³ªÅ¸³ª±â Àü±îÁö´Â Áõ»óÀÌ ³ªÅ¸³ªÁö ¾Ê±â ¶§¹®¿¡ ÀÌ·¯ÇÑ °Ë»ç¸¦ ÅëÇØ ½ÅÀå ÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇÏ´Â °ÍÀÌ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. Á¶±â Áø´ÜÀ» ÅëÇØ Àû½Ã¿¡ °³ÀÔÇÒ ¼ö ÀÖÀ¸¸ç, Áúº´ÀÇ ÁøÇàÀ» ´ÊÃß°í ÇÕº´ÁõÀ» ¿¹¹æÇϸç ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÅÀå ÁúȯÀÇ ÁÖ¿ä À§Çè ¿äÀÎÀÎ ´ç´¢º´, °íÇ÷¾Ð°ú °°Àº ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Á¤±âÀûÀÎ °Ç°­ °ËÁø ¹× ¸¸¼ºÁúȯ °ü¸®ÀÇ ÀÏȯÀ¸·Î Á¤±âÀûÀÎ ½ÅÀå ±â´É °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº ¾î¶»°Ô ½ÅÀå ±â´É °Ë»ç¸¦ °­È­Çϴ°¡?

±â¼úÀÇ ¹ßÀüÀº ½ÅÀå ±â´É °Ë»çÀÇ Á¤È®¼º, ÆíÀǼº ¹× Á¢±Ù¼ºÀ» Å©°Ô Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÇöÀå °Ë»ç Àåºñ¿Í °°Àº Áø´Ü ±â¼úÀÇ Çõ½ÅÀº ±âÁ¸ °Ë»ç½Ç ¹Û¿¡¼­ ½Å¼ÓÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ½ÅÀå ±â´É Æò°¡¸¦ °¡´ÉÇÏ°Ô ÇÏ¿© ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ȯÀÚ¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÀå Àå¾Ö¿Í ±â´É¿¡ ´ëÇÑ º¸´Ù Á¤È®ÇÑ Á¤º¸¸¦ Á¦°øÇϴ ÷´Ü ¹ÙÀÌ¿À¸¶Ä¿ÀÇ °³¹ß·Î ÀÌ·¯ÇÑ °Ë»çÀÇ ¹Î°¨µµ°¡ Çâ»óµÇ¾î ½ÅÀå ÁúȯÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ½ÅÀå ±â´É °Ë»ç¿Í µðÁöÅÐ °Ç°­ Ç÷§Æû ¹× ÀüÀÚ ÀÇ·á ±â·Ï(EMR)°úÀÇ ÅëÇÕÀº µ¥ÀÌÅÍ °ü¸®¸¦ °£¼ÒÈ­ÇÏ¿© ÀÇ·á Àü¹®°¡°¡ ȯÀÚÀÇ °æ°ú¸¦ º¸´Ù È¿°úÀûÀ¸·Î ÃßÀûÇϰí Á¤º¸¿¡ ÀÔ°¢ÇÑ Ä¡·á ¹æÄ§À» °áÁ¤ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ¸¸¼ºÁúȯÀ» °ü¸®Çϰí ÀÇ·á ½Ã½ºÅÛ¿¡¼­ ½ÅÀå ÁúȯÀÇ ºÎ´ãÀ» ÁÙÀÌ´Â µ¥ ƯÈ÷ À¯¿ëÇÕ´Ï´Ù.

½ÅÀå ±â´É °Ë»ç ½ÃÀå¿¡´Â ¾î¶² ¹®Á¦°¡ Àִ°¡?

½ÅÀå ±â´É °Ë»ç ½ÃÀåÀº °Ë»ç¿¡ ´ëÇÑ Á¢±Ù¼º °ÝÂ÷, °á°ú ÇØ¼®ÀÇ º¹À⼺, ´ëÁß¿¡ ´ëÇÑ ÀÎ½Ä °³¼±ÀÇ Çʿ伺 µî ¿©·¯ °¡Áö °úÁ¦¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. Àü ¼¼°è ¸¹Àº Áö¿ª, ƯÈ÷ ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­´Â °í±Þ ½ÅÀå ±â´É °Ë»ç¿¡ ´ëÇÑ Á¢±ÙÀÌ Á¦ÇÑµÇ¾î ½ÅÀå ÁúȯÀÇ Áø´Ü°ú Ä¡·á°¡ Áö¿¬µÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ °Ë»ç °á°úÀÇ ÇØ¼®Àº º¹ÀâÇÒ ¼ö ÀÖÀ¸¸ç, ƯÈ÷ °í·ÉÀÚ³ª µ¿¹Ý ÁúȯÀ» ¾Î°í Àִ ȯÀÚ µî ¿©·¯ ¿äÀÎÀÌ ½ÅÀå ±â´É¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °æ¿ì¿¡´Â ´õ¿í º¹ÀâÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹À⼺Àº ¼÷·ÃµÈ ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ ´ëÀÀÇÏÁö ¾ÊÀ¸¸é ¿ÀÁøÀ̳ª °ú¼Ò Áø´ÜÀ¸·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ Á¤±âÀûÀÎ ½ÅÀå ±â´É °Ë»çÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ºÎÁ·Çϸç, ƯÈ÷ ½ÅÀå ÁúȯÀÇ À§ÇèÀÌ ³ôÀº »ç¶÷µé »çÀÌ¿¡¼­ ±× Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ºÎÁ·ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ À̵¿ Áø·á¼Ò, ¿ø°Ý Áø·á, Áö¿ª º¸°Ç ÇÁ·Î±×·¥À» ÅëÇØ °Ë»ç Á¢±Ù¼ºÀ» °³¼±Çϰí, ½ÅÀå °Ç°­ ¹× Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ´ëÁßÀÇ ÀνÄÀ» °³¼±Çϱâ À§ÇÑ ³ë·ÂÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù.

½ÅÀå ±â´É °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀº ¹«¾ùÀΰ¡?

½ÅÀå ±â´É °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀº ¸¸¼º ½ÅÀå Áúȯ(CKD)ÀÇ À¯º´·ü Áõ°¡, Áø´Ü ±â¼úÀÇ ¹ßÀü, ¿¹¹æ ÀÇÇп¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇÕ´Ï´Ù. ´ç´¢º´, °íÇ÷¾Ð µî ½ÅÀå Àå¾Ö¸¦ À¯¹ßÇÏ´Â ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Á¤±âÀûÀÎ ½ÅÀå ±â´É °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½ÃŰ´Â ÁÖ¿ä ¿äÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. º¸´Ù Á¤È®ÇÏ°í ºü¸¥ °Ë»ç ¹æ¹ýÀÇ °³¹ß°ú °°Àº ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ÀÌ·¯ÇÑ °Ë»ç°¡ ´õ¿í Ä£¼÷ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ°Ô µÇ¾î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀáÀçÀûÀÎ °Ç°­ ¹®Á¦¸¦ Á¶±â¿¡ ¹ß°ßÇÏ°í °ü¸®ÇÏ´Â °ÍÀ» ¿ì¼±½ÃÇÏ´Â ¿¹¹æÀû °Ç°­°ü¸®·ÎÀÇ ÀüȯÀº Á¤±âÀûÀÎ °Ç°­°ËÁø¿¡ ½ÅÀå ±â´É °Ë»ç°¡ ÅëÇյǴ °ÍÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®´ë¿Í ÇöÀå °Ë»ç ¼Ö·ç¼ÇÀÇ °¡¿ë¼º È®´ëµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ½ÅÀå °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í °Ë»ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ °³¼±µÊ¿¡ µû¶ó ½ÅÀå ±â´É °Ë»ç ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 12»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Kidney Function Tests Market to Reach US$1.6 Billion by 2030

The global market for Kidney Function Tests estimated at US$1.1 Billion in the year 2023, is expected to reach US$1.6 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Dipsticks, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$765.0 Million by the end of the analysis period. Growth in the Disposables segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$303.3 Million While China is Forecast to Grow at 4.5% CAGR

The Kidney Function Tests market in the U.S. is estimated at US$303.3 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$244.4 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Kidney Function Tests Market - Key Trends & Medical Insights

Why Are Kidney Function Tests Crucial for Early Detection of Renal Diseases?

Kidney function tests are essential diagnostic tools used to assess how well the kidneys are working and to detect any signs of kidney disease or dysfunction at an early stage. These tests typically measure parameters such as serum creatinine, blood urea nitrogen (BUN), glomerular filtration rate (GFR), and urine albumin, which provide crucial insights into kidney health. Early detection of kidney issues through these tests is vital because chronic kidney disease (CKD) often progresses silently, with symptoms only becoming apparent in advanced stages. Early diagnosis enables timely intervention, which can slow disease progression, prevent complications, and improve patient outcomes. The rising prevalence of conditions such as diabetes and hypertension, which are major risk factors for kidney disease, is driving the demand for routine kidney function testing as part of regular health check-ups and chronic disease management.

How Are Technological Advancements Enhancing Kidney Function Tests?

Technological advancements are significantly enhancing the accuracy, convenience, and accessibility of kidney function tests. Innovations in diagnostic technology, such as point-of-care testing devices, are enabling rapid and reliable kidney function assessments outside of traditional laboratory settings, making it easier for healthcare providers to monitor patients in real-time. The development of advanced biomarkers that provide more precise information about kidney damage and function is also improving the sensitivity of these tests, allowing for earlier detection of kidney disease. Additionally, the integration of kidney function testing with digital health platforms and electronic medical records (EMRs) is streamlining data management, enabling healthcare professionals to track patient progress more effectively and make informed treatment decisions. These advancements are particularly beneficial in managing chronic conditions and reducing the burden of kidney disease on healthcare systems.

What Challenges Are Present in the Kidney Function Tests Market?

The kidney function tests market faces several challenges, including disparities in access to testing, the complexity of interpreting results, and the need for better public awareness. In many parts of the world, especially in low-resource settings, access to advanced kidney function tests is limited, which can delay diagnosis and treatment of kidney disease. Additionally, interpreting the results of these tests can be complex, particularly in cases where multiple factors affect kidney function, such as in elderly patients or those with comorbidities. This complexity can lead to misdiagnosis or underdiagnosis if not handled by experienced healthcare providers. Moreover, there is a lack of public awareness about the importance of regular kidney function testing, especially among individuals at higher risk of kidney disease. To address these challenges, efforts are being made to improve access to testing through mobile health units, telemedicine, and community health programs, while also educating the public about the importance of kidney health and early detection.

What Factors Are Driving Growth in the Kidney Function Tests Market?

The growth in the kidney function tests market is driven by several factors, including the increasing prevalence of chronic kidney disease (CKD), advancements in diagnostic technologies, and the growing emphasis on preventive healthcare. The rising incidence of diabetes, hypertension, and other conditions that can lead to kidney damage is a major driver of the demand for regular kidney function testing. Technological advancements, such as the development of more accurate and rapid testing methods, are making these tests more accessible and reliable, further supporting market growth. Additionally, the shift towards preventive healthcare, where early detection and management of potential health issues are prioritized, is driving the integration of kidney function tests into routine medical screenings. The expansion of healthcare infrastructure in emerging markets and the growing availability of point-of-care testing solutions are also contributing to the market’s expansion. As awareness of kidney health increases and access to testing improves, the kidney function tests market is expected to continue growing.

Select Competitors (Total 12 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â